Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Teva Pharmaceutical (TEVA)

NYSE:TEVA

US Market

TEVA

Teva Pharmaceutical

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Teva Pharmaceutical (TEVA) Stock News & Sentiment

7,309 Followers

Teva Pharmaceutical’s Austedo Poised for Growth: Analyst Recommends Buy Rating

Ratings

Teva Pharmaceutical’s Austedo Poised for Growth: Analyst Recommends Buy Rating

3d ago

Teva Pharmaceutical’s Promising Growth Prospects and Strategic Initiatives Drive Buy Rating

Ratings

Teva Pharmaceutical’s Promising Growth Prospects and Strategic Initiatives Drive Buy Rating

9d ago

Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating

Ratings

Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating

1M ago

Teva Pharmaceutical Elects New Board Members at Annual Meeting

Company Announcements

Teva Pharmaceutical Elects New Board Members at Annual Meeting

1M ago

Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts

Weekend Updates

Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts

2M ago

Teva Pharmaceutical’s Promising Long-term Outlook: Buy Rating Backed by Strategic Initiatives and FCF Growth Potential

Ratings

Teva Pharmaceutical’s Promising Long-term Outlook: Buy Rating Backed by Strategic Initiatives and FCF Growth Potential

2M ago

Teva Pharmaceutical Issues Senior Notes for Debt Management

Company Announcements

Teva Pharmaceutical Issues Senior Notes for Debt Management

2M ago

More TEVA News >

TEVA News on the Web

2025-07-16

JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise

Zacks

Neutral

2025-07-11

TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock?

Zacks

Neutral

2025-06-23

J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?

Zacks

Neutral

2025-06-23

Teva Pharmaceutical Industries Presents Final Analysis of PEARL Study Demonstrating Sustained Effectiveness of AJOVY in Migraine Prevention at EAN 2025 Congress

Quiver Quantitative

Neutral

2025-06-21

Leader Capital Markets Remains a Buy on Teva (TEVA)

TipRanks News

Neutral

2025-06-17

Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy

Zacks

Neutral

2025-06-16

Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters

The Motley Fool

Neutral

2025-06-12

Teva 'well positioned for upside from here,' says JPMorgan

The Fly

Neutral

News Score - Last 7 Days

Neutral

TEVA

Sector Average

Media Buzz

This Week1 articles

Weekly Average1.25 articles

News Sentiment

This Week50%

Sector Average56%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TEVA’s Media Buzz Sentiment?

1 articles about TEVA were published this week. In an average week, 1.25 articles are published.

What is TEVA’s weekly average amount of articles?

In an average week, 1.25 articles about TEVA are published.

What is TEVA’s News Sentiment?

50% of articles about TEVA were positive this week, compared to its sector average of 56%.

Healthcare Stocks that are Trending in the News

NEVIPascal Biosciences Inc

JNJJohnson & Johnson

HRMYHarmony Biosciences Holdings

ABTAbbott Laboratories

WATWaters

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing